These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
254 related items for PubMed ID: 9723445
1. Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival. Stepkowski SM, Wang M, Qu X, Yu J, Okamoto M, Tejpal N, Kahan BD. Transplant Proc; 1998 Aug; 30(5):2214-6. PubMed ID: 9723445 [No Abstract] [Full Text] [Related]
2. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus. Wang ME, Tejpal N, Qu X, Yu J, Okamoto M, Stepkowski SM, Kahan BD. Transplantation; 1998 Apr 15; 65(7):899-905. PubMed ID: 9565092 [Abstract] [Full Text] [Related]
3. FTY720 blocks allograft rejection by homing of lymphocytes in vivo. Yuzawa K, Stephkowski SM, Wang M, Kahan BD. Transplant Proc; 2000 Mar 15; 32(2):269. PubMed ID: 10715413 [No Abstract] [Full Text] [Related]
4. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival. Stepkowski SM, Kahan BD. Transplant Proc; 1991 Dec 15; 23(6):3262-4. PubMed ID: 1750091 [No Abstract] [Full Text] [Related]
5. Effect of a novel immunosuppressant, FTY720, on heart and liver transplantations in rats. Yamashita K, Nomura M, Omura T, Takehara M, Suzuki T, Shimamura T, Kishida A, Furukawa H, Murakami M, Uede T, Todo S. Transplant Proc; 1999 Dec 15; 31(1-2):1178-9. PubMed ID: 10083526 [No Abstract] [Full Text] [Related]
6. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats. Hamashima T, Stepkowski SM, Smith S, Kahan BD. Transplant Proc; 1994 Oct 15; 26(5):3053-5. PubMed ID: 7940960 [No Abstract] [Full Text] [Related]
7. FTY720, a novel immunosuppressant, shows a synergistic effect in combination with FK 506 in rat allograft models. Hoshino Y, Yanagawa Y, Ohtsuki M, Nakayama S, Hashimoto T, Chiba K. Transplant Proc; 1999 Oct 15; 31(1-2):1224-6. PubMed ID: 10083547 [No Abstract] [Full Text] [Related]
8. Rescue therapy with rapamycin blocks an ongoing process of heart allograft rejection. Ferraresso M, Wang ME, Stepkowski SM, Kahan BD. Transplant Proc; 1993 Feb 15; 25(1 Pt 1):729. PubMed ID: 8438460 [No Abstract] [Full Text] [Related]
9. Rescuing acute rejection of rat cardiac allografts with FTY720. Chueh SC, Tsai CC, Chiu B, Li YC, Lai MK. Transplant Proc; 2000 Nov 15; 32(7):1629-30. PubMed ID: 11119868 [No Abstract] [Full Text] [Related]
10. Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat. Chen H, Wu J, Luo H, Daloze P. Transplant Proc; 1992 Jun 15; 24(3):892-3. PubMed ID: 1604658 [No Abstract] [Full Text] [Related]
11. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A. Hoshino Y, Suzuki C, Ohtsuki M, Masubuchi Y, Amano Y, Chiba K. Transplant Proc; 1996 Apr 15; 28(2):1060-1. PubMed ID: 8623226 [No Abstract] [Full Text] [Related]
12. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models. Nikolova Z, Hof A, Baumlin Y, Hof RP. Transpl Immunol; 2001 Feb 15; 8(4):267-77. PubMed ID: 11316070 [Abstract] [Full Text] [Related]
13. Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice. Stepkowski SM, Tu Y, Chou TC, Kahan BD. Transplant Proc; 1994 Oct 15; 26(5):3025-7. PubMed ID: 7940952 [No Abstract] [Full Text] [Related]
14. An effect of FTY720 on acute rejection in canine renal transplantation. Yuzawa K, Otsuka M, Taniguchi H, Takada Y, Sakurayama N, Jinzenji Y, Suzuki S, Fukao K. Transplant Proc; 1998 Jun 15; 30(4):1046. PubMed ID: 9636422 [No Abstract] [Full Text] [Related]
15. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats. Chiba K, Hoshino Y, Suzuki C, Masubuchi Y, Yanagawa Y, Ohtsuki M, Sasaki S, Fujita T. Transplant Proc; 1996 Apr 15; 28(2):1056-9. PubMed ID: 8623225 [No Abstract] [Full Text] [Related]
16. Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720. Suzuki S, Enosawa S, Kakefuda T, Amemiya H, Hoshino Y, Chiba K. Transplant Proc; 1996 Jun 15; 28(3):1375-6. PubMed ID: 8658701 [No Abstract] [Full Text] [Related]
17. FTY720 compares with FK 506 as rescue therapy in rat heterotopic cardiac transplantation. Xu M, Pirenne J, Antoniou S, Gunson B, D'Silva M, McMaster P. Transplant Proc; 1998 Aug 15; 30(5):2221-2. PubMed ID: 9723447 [No Abstract] [Full Text] [Related]
18. Combined use of FTY720 and cyclosporine A prevents chronic allograft vasculopathy. Koshiba T, Van Damme B, Lu Y, Yan Y, Rutgeerts O, Overbergh L, Tanaka K, Waer M, Mathieu C, Pirenne J. Transplant Proc; 2002 May 15; 34(3):748-9. PubMed ID: 12034170 [No Abstract] [Full Text] [Related]
19. Combined effect of rapamycin and cyclosporine in the prevention of rat corneal allograft rejection. Thompson P, Xu D, Brunette I, Chen H. Transplant Proc; 1998 Jun 15; 30(4):1033-5. PubMed ID: 9636417 [No Abstract] [Full Text] [Related]
20. Effects of mycophenolate sodium with or without FTY720 in a DA-to-Lewis rat heart transplantation model. Matsumoto Y, Hof RP. Transplant Proc; 2002 Nov 15; 34(7):2891-2. PubMed ID: 12431647 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]